HARROW, INC. — Director's Dealing 2015

Apr 28, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2015-04-23

Reporting Person: Kammer Robert J (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-23	Common Stock	M	15282	$5.925	Acquired	988546	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-04-23	Warrant (Right to Buy)	$5.925	M	15282	Disposed	2015-04-25	Common Stock (15282)	Direct

Footnotes

F1: The original warrant, for 48,261 shares of the Issuer's common stock, was issued on April 25, 2012 to DermaStar International, LLC ("DermaStar"), which was dissolved in July 2012. As a member of DermaStar at the time of its dissolution, the portion of the warrant granting the right to acquire 15,282 shares of the Issuer's common stock was distributed by DermaStar to Dr. Kammer on July 12, 2012. The warrant is fully exercisable.